Effectiveness of a Socio-Community Health Intervention on Pre-Frailty in Older Adults

October 28, 2024 updated by: Keralty SAS. Colombia

Effectiveness of a Health Intervention With a Socio-community Approach on Frailty in Older Adults With Pre-frailty

The objective of this study is: To evaluate the effectiveness of a health intervention with a socio-community approach on frailty in older adults with pre-frailty.

Specific Objectives:

To characterize the study population according to sociodemographic and clinical variables.

To evaluate the effect of the intervention on the functionality domain at 3 and 6 months.

To evaluate the effect of the intervention on the cognitive-emotional domain at 3 and 6 months.

To evaluate the effect of the intervention on the socio-community domain at 3 and 6 months.

To evaluate the effect of the intervention on frailty in older adults. To determine the proportion of participants hospitalized during the study period.

To determine the proportion of participants who visited the emergency room during the study period.

To determine the proportion of participants in long-term care facilities. To determine the proportion of adverse events associated with the intervention.

Study Hypothesis

The mean frailty score pre-intervention is equal to the mean frailty score post-intervention.

The mean frailty score pre-intervention is different from the mean frailty score post-intervention.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nancy Yomayusa Gonzalez, Dr
  • Phone Number: +57 601 4871920
  • Email: igek@keralty.com

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Individuals ≥ 60 years old classified as pre-frail in the last 3 months and documented in their medical history.
  • Individuals who meet the requirements and provide voluntary informed consent for their participation.
  • Individuals available to remain in Bogotá D.C. during the study period.

Exclusion Criteria:

  • Individuals receiving care at community-focused medical centers.
  • Individuals attending community dining programs, physical activity programs, community groups, care blocks, volunteering, or other related activities.
  • Individuals who have experienced falls in the last 6 months with clinical consequences (hospitalization, fractures, traumatic brain injury).
  • Individuals with a clinical history of moderate cognitive impairment, neurodegenerative diseases (e.g., Parkinson's disease), and/or neuro-musculoskeletal disorders, active cancer, end-stage renal disease, unstable ischemic heart disease, uncontrolled arrhythmias, severe aortic stenosis, uncontrolled hypertension (>180/100 mmHg), or advanced heart failure, exacerbation of chronic diseases (COPD, heart failure), unrehabilitated severe hearing loss, deafness, or blindness with communication limitations.
  • Acute conditions requiring hospitalization, such as acute myocardial infarction or urinary tract infections.
  • Bone fractures in the last 3 months.
  • Individuals unable to follow instructions or with behavioral changes that hinder their participation in the study.
  • Individuals with severe psychiatric illness that, in the physician's judgment, prevents proper adherence to the study intervention.
  • Institutionalized individuals in long-term care facilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group

Education Component: Lectures and workshops aimed at enhancing awareness and personal growth through knowledge and emotional reflection.

Cognitive Component: One-hour sessions divided into introduction (15 min), cognitive stimulation activities (35 min), and closure with reflection and a brief survey.

Physical Activity Component: A 10-minute warm-up, followed by 30 minutes of guided exercises for balance, coordination, and strength, ending with a 10-minute cool-down.

Nutrition Component: Practical workshops focused on healthy eating, including menu planning and food preparation.

Socio-Community and Occupational Component: Encourages community integration and social networking, with gardening activities for growing herbs and vegetables.

Autonomous Activities: Participants implement physical activity recommendations in daily life, with weekly follow-ups by the research team using the RedCap platform for monitoring.

The intervention consists of five components, including education, cognitive stimulation, physical activity, nutrition, and socio-community aspects. The duration of the intervention will be 6 months and will be conducted in either in-person or virtual format, individually or in groups, depending on the nature of each component. Mode of Delivery:

The intervention will be offered in both in-person and synchronous virtual formats. Participants who are unable to attend in person or who face difficulties doing so on any occasion will have the option to join the sessions through a real-time videoconferencing platform. In both modalities, the professionals in charge will supervise and guide the activities, ensuring proper execution and adherence to the study's objectives. The research team will maintain a detailed record of attendance and participation using the RedCap platform for appropriate tracking.

No Intervention: Control group
The control group will maintain the usual care provided by their healthcare service provider.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score on the FRAIL Scale
Time Frame: Baseline, 3, 6 Months
Frailty will be assessed using the FRAIL Scale, which evaluates five domains: fatigue, resistance, ambulation, illnesses, and weight loss. The total score ranges from 0 to 9, where higher scores indicate greater frailty
Baseline, 3, 6 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barthel Index
Time Frame: Baseline, 3, 6 Months
Measures independence in basic activities of daily living. The score ranges from 0 to 100, where higher scores indicate greater independence.
Baseline, 3, 6 Months
Lawton Score
Time Frame: Baseline, 3, 6 Months
Assesses instrumental activities of daily living (IADLs), with a score range of 0 to 8. Higher scores indicate better ability to perform IADLs independently.
Baseline, 3, 6 Months
Downton Scale
Time Frame: Baseline, 3, 6 Months
Evaluates the risk of falls in older adults, considering factors such as previous falls, medication use, sensory deficits, mental status, and walking ability. The score ranges from 0 to 14, where higher scores indicate a higher risk of falls.
Baseline, 3, 6 Months
Score on the Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline, 3, 6 Months
The MoCA is a global cognitive screening tool that assesses memory, attention, language, abstraction, executive function, calculation, and orientation. Scores range from 0 to 30, with higher scores indicating better cognitive function
Baseline, 3, 6 Months
Score on the Yesavage Geriatric Depression Scale (GDS)
Time Frame: Baseline, 3, 6 Months
The GDS is a tool used to assess depression in older adults, with scores ranging from 0 to 15. Higher scores indicate more severe depression.
Baseline, 3, 6 Months
Score on the Gijón Family-Social Assessment Scale
Time Frame: Baseline, 3, 6 Months
The Gijón Family-Social Assessment Scale evaluates the socio-family situation of the patient, considering factors such as economic situation, family relationships, and social support. The score ranges from 0 to 15, with higher scores indicating greater socio-family vulnerability
Baseline, 3, 6 Months
Score on the Lubben Social Network Scale
Time Frame: Baseline, 3, 6 Months
The Lubben Social Network Scale assesses the social support and contact network of an individual, with a score range of 0 to 30. Higher scores indicate a stronger social support network.
Baseline, 3, 6 Months
Health-Related Quality of Life Measured by EQ-5D-3L
Time Frame: Baseline, 3, 6 Months
The EQ-5D-3L is a health-related quality of life measurement tool that consists of two parts: a descriptive system covering five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a Visual Analogue Scale (VAS) where participants rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health). The descriptive system generates a health profile, and the VAS provides a quantitative measure of perceived overall health.
Baseline, 3, 6 Months
Number of Hospital Admissions
Time Frame: During the 6-month intervention
The total number of hospital admissions recorded during the 6-month intervention period.
During the 6-month intervention
Total Number of Hospitalization Days
Time Frame: During the 6-month intervention
The total number of days spent in the hospital, summing all admissions during the 6-month intervention period.
During the 6-month intervention
Total Number of Emergency Room Admissions
Time Frame: During the 6-month intervention.
The total number of emergency room admissions recorded during the 6-month intervention period.
During the 6-month intervention.
Requirement for Admission to Long-Term Care Facilities
Time Frame: During the 6-month intervention.
This measure tracks whether participants require admission to long-term care facilities during the 6-month intervention period.
During the 6-month intervention.
Utilization of Social Health Assets
Time Frame: During the 6-month intervention.
This measure tracks the use of social health services, including community-based resources,
During the 6-month intervention.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Events
Time Frame: During the 6-month intervention.
Adverse events refer to any undesirable experiences or occurrences resulting from the intervention, including but not limited to side effects, complications, or unexpected outcomes. All adverse events will be recorded and categorized based on their severity (e.g., mild, moderate, severe) and their relationship to the intervention (e.g., related, possibly related, unrelated)
During the 6-month intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Lina Sofía Morón-Duarte, PhD, keralty

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2024

Primary Completion (Estimated)

November 30, 2025

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

October 24, 2024

First Submitted That Met QC Criteria

October 28, 2024

First Posted (Actual)

October 29, 2024

Study Record Updates

Last Update Posted (Actual)

October 29, 2024

Last Update Submitted That Met QC Criteria

October 28, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 092-24 UNV

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Clinical Trials on health intervention with a socio-community approach

Subscribe